Conquering melanoma and skin cancer
Melanoma and Skin Cancer Trials (MASC Trials) specialises in investigator-initiated melanoma and skin cancer research.
We work collaboratively with world-leading researchers to deliver clinical trials that improve melanoma and skin cancer outcomes.
Since 1999, we have delivered melanoma and skin cancer clinical trials
Clinical trials save lives - donate today
Melanoma and skin cancer do not discriminate. These cancers affect young and old, men and women, in big cities and in small towns.
Donate now and support our most promising researchers to improve treatments for melanoma and skin cancers, and give survivors long and healthy lives.
What We Do
Melanoma and Skin Cancer Trials Ltd works with world-leading researchers to deliver clinical trials that improve melanoma and skin cancer outcomes. We are the only independent, not-for-profit, multi-site, collaborative clinical trials group focused on melanoma and skin cancer in Australia and New Zealand.
From early engagement with consumers and researchers to develop research concepts, through to the publication of results, we work cooperatively to provide a range of clinical trial services.
Active Trials Closed for Recruitment
Trials in Start-Up Phase
Melanoma and Skin Cancer Trials and the Victorian Heart Institute are leading an Australian-first trial to determine if a common cholesterol medication can reduce the risk of heart attacks in melanoma patients treated with cancer therapy.
A $110,000 donation to a new trial treating melanoma brain metastases will help open additional research sites around Australia, offering hope to patients, like Peter Wilson, who have melanoma that has spread to the brain.
MASC Trials, MSCAN and BlazeAid have partnered to deliver sun safety educational videos for BlazeAid volunteers so they know how to protect their skin during frontline disaster response work.